Launch of company Gate2Brain, based on a novel technology to transport drugs into brain


From left to right, Emili Bargalló (Fundació Sant Joan de Déu), Carme Verdaguer (Bosch i Gimpera Foundation), Marc Ramis (Chasing Science), Meritxell Teixidó (Gate2Brain), and Esther Riambau (Gate2Brain), Francesc Posas (IRB Barcelona).

From left to right, Emili Bargalló (Fundació Sant Joan de Déu), Carme Verdaguer (Bosch i Gimpera Foundation), Marc Ramis (Chasing Science), Meritxell Teixidó (Gate2Brain), and Esther Riambau (Gate2Brain), Francesc Posas (IRB Barcelona).

Researchers from IRB Barcelona, the University of Barcelona (UB) and Sant Joan de Déu Research Institute – Hospital Sant Joan de Déu (SJD) have set up Gate2Brain, a company based on a novel technology developed at IRB Barcelona to transport drugs into the brain. Gate2Brain is the second joint spin-off by IRB Barcelona and the UB to be funded by the Mind the Gap Programme, from the Botín Foundation.

/Public Release. The material in this public release comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here.